We use cookies in order to analyze traffic of this website. Your further use of this website will be considered consent. For more information visit our Cookie Policy.

Scientific Presentations

  • Crenezumab

    Safety, tolerability and pharmacokinetics of crenezumab in mild-to-moderate AD patients treated with escalating doses for up to 32.3 months
    Date: March 15, 2018 | 8.00am - 6.00pm CET
    Presenter: Poster presentation by Helen Lin, PhD - Genentech

    Download the PDF

  • SupraAntigen vaccine technology

    Development of highly sensitive MSD assays for the detection of anti-Abeta antibodies specific for pathological Abeta species and for Abeta peptide present on the liposomal vaccine
    Date: March 17, 2018 | 8:00am - 6:00pm CET
    Presenter: Poster presentation by Emma Fiorini, PhD - AC Immune

    Download the PDF

  • Alpha-synuclein-PET imaging agent

    Novel alpha-synuclein positron emission tomography (PET) tracers for the diagnosis of Parkinson's disease
    Date: March 15, 2018 | 3:40 - 4:40 pm CET
    Presenter: Oral presentation by Jan Stoehr, PhD - AC Immune

    Download the PDF